Posted on: May 22, 2012 by Angela Sormani
Benvenue Medical, a developer of minimally invasive solutions for spine repair, has appointed two new members to its board of directors. Thomas M. Prescott, president and CEO of Align Technology and Thomas C. Wilder, president and CEO of Sequent Medical are both experienced in bringing medical technologies to the global marketplace. Investors in Benvenue Medical [...]
Tags: DeNovo Ventures, Domain Associates, Technology Partners, Versant Ventures
Posted on: May 18, 2012 by Mark Boslet
Solar startup Solexel has raised $25 million in new capital, according to a filing with the Securities and Exchange Commission. No other details about the funding were available. The company received Series A financing in 2007 and a Series B round in 2008. Its board includes representatives of Kleiner Perkins Caufield & Byers, Technology Partners [...]
Tags: DAG Ventures, Kleiner Perkins Caufield & Byers, Solexel, Technology Partners
Posted on: April 25, 2012 by Mark Boslet
Van den Berg joined VantagePoint in 2006 from Venrock Partners and participated in the firm’s cleantech investing. He is a board member at Switch Lighting and Bridgelux, according to his LinkedIn profile
Tags: Bridgelux, Marc ven den Berg, Switch Lighting, Technology Partners, VantagePoint Capital Partners
Posted on: November 16, 2011 by Lawrence J. Aragon
Medley Health, which provides physician practice management services, announced Wednesday that it had raised $20 million in Series A financing from Cardinal Partners, Technology Partners and Vivo Ventures. The Dublin, Calif.-based company says it will use the capital to expand its physician partnerships, invest in its practice management services and boost staffing. ”As a physician, I understand firsthand [...]
Tags: Cardinal Partners, Health Care, Medley Health, Technology Partners, Vivo Ventures
Posted on: July 15, 2011 by Clancy Nolan
Transcend Medical Inc., a Menlo Park, Calif.-based ophthalmic device company, has closed a second tranche of its Series B round, bringing the total to an eye-popping $51 million. Investors include Investor Growth Capital, Canaan Partners, Finistere Ventures, HLM Venture Partners, Kaiser Permanente Ventures, Latterell Venture Partners, Morgenthaler Ventures, Split Rock Partners and Technology Partners. The company says it will use the funds to develop additional infrastructure and resources for a U.S. study of its micro-stent technology. The company is focused on minimally invasive glaucoma therapies.
Tags: Canaan Partners, Finistere Ventures, HLM Venture Partners, Investor Growth Capital, Kaiser Permanente Ventures, Latterell Venture Partners, Morgenthaler Ventures, Split Rock Partners, Technology Partners
Posted on: June 10, 2011 by Clancy Nolan
Revance Therapeutics Inc., a drug developer focused on dermatology and aesthetic medicine, has raised $45 million in new capital from Essex Woodlands Health Ventures, NovaQuest Capital, CNF Investments, Vivo Ventures, Technology Partners, Shepherd Ventures, Palo Alto Investors, Pac-Link Ventures and Essex Capital Corporation. Jonathan Tunnicliffe, a partner at NovaQuest, will join the Revance board as a result of the round. Revance closed a $25.62 million in Series D funding in late 2009.
Tags: CNF Investments, Essex Capital Corporation, Essex Woodlands Health Ventures, NovaQuest Capital, Pac-Link Ventures, Palo Alto Investors, Shepherd Ventures, Technology Partners, Vivo Ventures
Posted on: April 19, 2011 by Clancy Nolan
Benvenue Medical Inc., a Mountain View, Calif.-based developer of minimally invasive solutions for spine repair, has closed a $35.5 million Series C round. Domain Associates and Technology Partners co-led the round, which included support from existing shareholders Versant Ventures and DeNovo Ventures. Nimesh Shah, principal at Domain Associates, and Roger Quy, general partner of Technology Partners, will join the board as a result of the round.
Tags: DeNovo Ventures, Domain Associates, Technology Partners, Versant Ventures
Posted on: April 15, 2011 by Mark Boslet
Investment dollars inched higher in the first quarter as venture capitalists favored later stage deals and returned with interest to cleantech and life science, according to the MoneyTree Report by PricewaterhouseCoopers LLP and the National Venture Capital Association (NVCA), based on data from Thomson Reuters.
U.S. venture firms put $5.9 billion to work in the first three months of 2011, a 13% rise from Q1 2010 and a 5% increase from the fourth quarter, according to the report.
Tags: First Quarter, MoneyTree, Novak Biddle Venture Partners, Technology Partners, Venture Investments
Posted on: January 12, 2011 by Joanna Glasner
Uncertainties around health care reform and the complexities of medical reimbursement weighed heavily on the business models of most presenting companies at this week’s J.P. Morgan Healthcare Conference. Not so, however, for Kythera Biopharmaceuticals, a Calabasas, Calif.-based developer of cosmetic treatments that took the stage yesterday to talk up prospects for what it sees as [...]
Tags: Aisling Capital, ARCH Venture Partners, De Novo Ventures, JAFCO, Prospect Venture Partners, Technology Partners, Versant Ventures, Vivo Ventures
Posted on: December 15, 2010 by Clancy Nolan
Abound Solar, which is developing cadmium telluride, thin-film photovoltaic solar modules, has inked a $400 million loan guarantee from the U.S. Department of Energy. The company has also raised $110 million in equity financing, bringing the total equity raised to $260 million. Existing investors Invus Group, Bohemian Companies, DCM and Technology Partners participated in the new round. New investors BP Alternative Energy Ventures and West Hill Companies also participated. The funding will help Abound Solar expand its manufacturing capacity at sites in Colorado and Indiana.
Tags: DCM, Invus Group, Technology Partners